<DOC>
	<DOC>NCT00436527</DOC>
	<brief_summary>This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application.</brief_summary>
	<brief_title>Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application</brief_title>
	<detailed_description>This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application as measured by the Corneometer CM 825.</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Clinical diagnosis of moderate to severe rosacea, defined as the presence of at least moderate erythema with telangiectasia and a minimum of two inflammatory lesions Individuals with active symptoms of allergy (mild active seasonal allergies are acceptable) or atopic dermatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>